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An increasing number of scientific studies support that flavanol-rich foods and beverages such as cocoa can promote human health, and are
beneficial agents for the prevention of some diseases. Our previous studies showed that long-term cocoa intake enhances the antioxidant status
in lymphoid organs and also modulates lymphocyte functionality in healthy young rats. Cocoa polyphenolic antioxidants seem to be the best
candidates for those effects. However, data regarding polyphenol metabolites in tissues after a long-term cocoa intake are scarce. In the present
study we mainly focus on the uptake and accumulation of epicatechin metabolites in lymphoid organs, including the thymus, spleen and mesenteric
lymphoid nodes, as well as in the liver and testes after a diet rich in cocoa. Ten young weaned Wistar rats were fed randomly with a 10 % (w/w)
cocoa diet or a control diet for 3 weeks, corresponding to their infancy and youth. Tissues were treated with a solid-phase extraction and analysed
by liquid chromatography–tandem MS. The major compounds recovered in these tissues were glucuronide derivatives of epicatechin and methy-
lepicatechin. The highest concentration of these metabolites was found in the thymus, testicles and liver, followed by lymphatic nodes and spleen.
The high amount of epicatechin metabolites found in the thymus supports our previous findings showing its high antioxidant capacity compared
with other tissues such as the spleen. Moreover, this is the first time that epicatechin metabolites have been found in high concentrations in the
testes, confirming other studies that have suggested the testes as an important site of oxidation.
Epicatechin metabolites: Cocoa: Lymphoid tissues: Testes
Cocoa (Theobroma cacao) has been consumed since 600 BC,
when the Mayans and Aztecs considered it to be a divine
food(1). Nowadays, cocoa is consumed as chocolate and
other confectionery products throughout the world. Cocoa
has become of increasing interest due to its high content of
polyphenolic compounds, particularly flavonoids – mainly
flavanols, including (2 )-epicatechin, (þ)-catechin and
polymeric procyanidins(2).
Cocoa flavonoids have been linked to beneficial health
effects, mainly in chronic diseases such as CVD(3), but also
preventing certain kinds of cancer(4), improving brain
function(5) and modulating immune response(6,7). The effects
of cocoa on the immune system are less well known and
most of the studies are performed in vitro showing the modu-
latory effects of cocoa extracts and its isolated polyphenols on
stimulated macrophages(8) and lymphocytes(9,10). However,
these in vitro effects from cocoa cannot be extrapolated
to in vivo function since the bioavailability and metabolism
of its polyphenols must be taken into account. Mono-
meric flavanols are stable during gastric transit(11), although
controversial data in the degradation or not of procyanidin
oligomers in the stomach have been reported(11,12). After
gastric transit, flavanols are absorbed from the jejunal lumen
into the epithelial cell layer and metabolised in the intestine
in methyl and glucuronide conjugates, with an additional
glucuronidation, methylation and sulfation in the liver, both
in rats and humans(13,14). Consequently, flavanol conjugates
are found in the plasma and urine of experimental animals
after their intake(15). Therefore, studies on the bioavailability
of flavonoids and their metabolites are now playing a crucial
role in the understanding of the health-promoting properties
of flavonoids.
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We previously found that long-term cocoa intake by healthy
young rats enhances antioxidant status in lymphoid organs.
Certainly, cocoa intake promotes the progression of immature
thymocytes towards more mature T cell stages in the thymus,
and modulates lymphocyte functionality in both intestinal and
systemic compartments(6,16). Taking into account the effects
of a cocoa diet on the immune function, the aim of the present
study was to investigate which are the specific epicatechin
metabolites from regular 10 % cocoa diet consumption, and
their distribution and concentration in young rat lymphoid
organs. Furthermore, we have considered the accumulation
of metabolites in the testes as a specific target organ since
previous studies have shown that flavonoids such as quercetin
affect sperm quality(17).
Methods
Materials
Reagents and standards were obtained from the following
sources: methanol and acetonitrile (HPLC grade) from
Scharlau (Barcelona, Spain); formic acid, (2 )-epicatechin
and ethyl gallate from Sigma-Aldrich-Fluka (St Louis,
MO, USA); taxifolin from Extrasynthe`se (Genay, France).
Standards of epicatechin-5-O-glucuronide, 30-O-methyle-
picatechin and 40-O-methylepicatechin were chemically
synthesised and characterised as previously published(18,19).
Ultrapure water (Milli-Q) was obtained from Millipore
(Bedford, MA, USA). The extraction cartridge plates were
Waters Oasisw Hydrophilic-Lipophilic Balance (HLB) (3 ml,
60 mg; Waters Corp., Milford, MA, USA).
Animals and experimental design
Wistar rats of 2 weeks of age (50 % male, 50 % female), with
their dam, were obtained from Harlan (Barcelona, Spain).
They were housed in cages of one dam with ten pups on a
12 h light–dark schedule. At the age of 3 weeks, pups were
weaned and randomly distributed in two different groups
(n 10) receiving, over a period of 3 weeks, (a) chow contain-
ing 10 % (w/w) natural cocoa or (b) control chow, and both
groups had free access to water. The chow used in the present
study was an American Institute of Nutrition (AIN)-93G
formulation. The 10 % (w/w) cocoa diet was produced from
modified AIN-93G containing 100 g cocoa per kg as described
previously(16). Studies were performed in accordance with
the institutional guidelines for the care and use of laboratory
animals, and experimental procedures were approved by
the Ethical Committee for Animal Experimentation of the
University of Barcelona (reference 3131).
Phenolic content of chow containing 10 % (w/w) natural
cocoa
The determination and quantification of individual phenolic
compounds (mg/g) in chow containing 10 % (w/w) natural
cocoa were analysed by HPLC as previously described(20)
and were found to be 0·34 (SD 0·01) mg (2 )-epicatechin/g,
0·10 (SD 0·004) mg (þ)-catechin/g and 0·23 (SD 0·01) mg
procyanidin B2/g(16).
Sample preparation
After 3 weeks of the cocoa or control diet, 6-week-old rats
were anesthetised and the thymus, spleen, liver, lymphoid
nodes and testes were excised. Organs were immediately
frozen in liquid N2, and then stored at 2808C until analysis.
Flavan-3-ol metabolites were extracted three times
(0·75 ml £ 3) with an ice-cold solution of 1·5 M-formic acid
with 5 % of methanol, using a Mixer Mill (Retsch MM 300,
Qiagen, Hilden, Germany) at 20 Hz during 0·5 min and
centrifuged each time at 14 000 rpm. Solid-phase extraction
was carried out using HLB cartridges (Waters Corp.).
Pooled supernatant fractions were loaded into preconditioned
cartridges with the internal standard (ethyl gallate) and
washed with 2 ml of 1·5 M-formic acid in water and with
2 ml of 5 % methanol in water. Elution was performed with
2 ml of 0·1 % formic acid in methanol. Eluate was evaporated
under an N2 stream and reconstituted with 100ml of taxifolin,
as an additional external standard, dissolved in mobile phase A
(0·1 % formic acid in water). Recoveries of the metabolites
were 85 (SD 13) % for epicatechin-5-O-glucuronide, 84 (SD
15) % for 30-O-methylepicatechin, 84 (SD 15) % for 40-O-
methylepicatechin and 88 (SD 10) % for epicatechin aglycone.
Liquid chromatography–tandem MS
Liquid chromatography analyses were performed using an
Agilent 1200 (Agilent Technologies, Waldbronn, Germany)
equipped with a quaternary pump and a refrigerated autosam-
pler. A triple quadrupole mass spectrometer (API 3000) from
Applied Biosystems (PE Sciex, Concord, ON, Canada),
equipped with a Turbo IonSpray source operated in the nega-
tive-ion mode, was used to obtain the MS/MS data. Liquid
chromatography–MS/MS methodology was performed as
previously published(13). Optimum MS/MS parameters were
optimised for each compound by infusion experiments. Data
were collected under the multiple reaction monitoring
(MRM) mode, tracking the transition of parent and product
ions specific for each compound. The MRM monitored the
following transitions in each analysis: epicatechin (289/245),
epicatechin glucuronide (465/289), epicatechin sulfate (369/
289), epicatechin sulfoglucuronide (545/289), methylepicate-
chin (303/137), methylepicatechin glucuronide (479/303),
methylepicatechin sulfate (383/303), methylepicatechin sulfo-
glucuronide (559/303), ethyl gallate as an internal standard
(197/169) and taxifolin (303/285) as an additional external
standard. For quantification purposes, calibration curves
were prepared in control tissues, in the range of expected con-
centrations, by supplementation with known concentrations of
epicatechin-5-O-glucuronide: 0, 0·2, 1, 2 and 4mmol/l. As no
other glucuronide conjugates were available, both epicatechin
and methylepicatechin glucuronides were quantified and
expressed as epicatechin-5-O-glucuronide equivalents. The
concentration of metabolites was expressed as mean values
with their standard errors of the mean (nmol/g tissue).
Results
After regular 3-week consumption of a 10 % (w/w) cocoa diet,
epicatechin metabolites were identified in rat tissue samples.
As shown in Fig. 1, one epicatechin glucuronide (MRM
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465/289) and two methylepicatechin glucuronides (MRM 479/
303) were identified in all tissues after the administration of
cocoa. Because the concentrations of these metabolites were
in the order of nmol/g tissue, identification was achieved by
the product ion scan of the deprotonated molecules in the
urine samples of the rats, as previously published(16). Free
methyl derivatives of epicatechin and sulfate and sulfoglucur-
onide conjugates were not detected in these tissues. No epica-
techin metabolites were found in animals fed the control diet.
The identified metabolites were quantified in the testicles,
liver, and in lymphoid tissues including the thymus, spleen
and lymphatic nodes (Table 1) by comparison with calibration
curves of epicatechin-5-O-glucuronide obtained in control
tissues. As far as we know, this is the first time that epicate-
chin glucuronides have been quantified using an actual
standard of epicatechin glucuronide. Previously, metabolites
were quantified with regard to the corresponding agly-
cone(13,21) or after sample hydrolysis(15). The highest concen-
trations of total metabolites, including glucuronide conjugates
of epicatechin and methylepicatechin, were found in the
thymus, testicles and liver in about 2-fold higher concen-
trations than in lymphatic nodes and spleen.
Taking into account the predominant metabolites in these
tissues, epicatechin glucuronide was found in the testicles
and thymus in higher concentrations than in the liver and
lymphoid nodes (about 1·5-fold). Moreover, the liver and
thymus were the organs with major amounts of total methyle-
picatechin glucuronides. Methylepicatechin glucuronide 2
was the major methylepicatechin glucuronide in all the tissues.
A significantly lower concentration of this compound was
observed in lymphoid nodes with respect to the liver and
thymus (about 2·7-fold lower). Methylepicatechin glucuronide
1 was found in the liver and thymus at significantly higher
concentrations than in the lymphoid nodes and spleen (about
7- and 6-fold, respectively), while significantly higher concen-
trations (of only about 2-fold) were observed in the testicles
when compared with the liver.
Discussion
The present study shows for the first time that epicatechin
metabolites are distributed in young rat lymphoid tissues,
testes and liver after exposure to a 10 % (w/w) cocoa diet
over 3 weeks. The cocoa used in the present study contained
mainly (2 )-epicatechin as the major flavanol. This compound,
which is stable during gastric transit(11) or comes from the
degradation of procyanidin oligomers(12), is absorbed in
the jejunal part of the intestine, where it is methylated and
glucuronidated, and then, in the liver, undergoes further
conjugation(13,14). In the present study, glucuronide conjugates
of epicatechin and methylepicatechin are the main metabolites
found in rat tissues. Positive identification of the methyl and
glucuronide metabolites of epicatechin detected in the sample
tissues was not possible as no standards of all of them are avail-
able. In the present study, the glucuronide standard used (epica-
techin-5-O-glucuronide) showed shorter retention time than the
glucuronide conjugate found in the rat tissues. Natsume et al. (22)
purified and elucidated the structure of epicatechin metabolites
in human and rat urine after oral administration of (2 )-epicate-
chin as (2 )-epicatechin-30-O-glucuronide, 40-O-methyl-(2 )-
epicatechin-30-O-glucuronide, and 40-O-methyl-(2 )-epicate-
chin 5 or 7-O-glucuronide in human urine, and 30-O-methyl-
(2 )-epicatechin, (2 )-epicatechin-7-O-glucuronide, and 30-O-
methyl-(2)-epicatechin-7-O-glucuronide in rat urine. In
accordance with Natsume’s findings, we tentatively identified
the glucuronide conjugate found in tissues of the present
study as (2 )-epicatechin-7-O-glucuronide, which is also
Table 1. Distribution of epicatechin metabolites in lymphoid organs and testes after a 10% (w/w) cocoa diet
(Mean values with their standard errors)
Epicatechin
glucuronide
(nmol/g tissue)*
Methylepicatechin
glucuronide 1
(nmol/g tissue)*
Methylepicatechin
glucuronide 2
(nmol/g tissue)*
Tissues Samples (n) Mean SEM Mean SEM Mean SEM
Liver 10 1·76 0·24 1·40 0·13 1·47 0·16
Lymphoid nodes 10 1·71 1·09 0·18 0·02 0·53 0·18
Spleen 10 0·80 0·61 0·23 0·03 1·22 0·39
Testicles 5 2·92 0·52 0·58 0·19 1·22 0·50
Thymus 10 2·43 0·29 1·27 0·13 1·39 0·18
*Expressed as epicatechin-5-O-glucuronide equivalents.
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Fig. 1. Representative multiple reaction monitoring (MRM) chromatograms of
epicatechin metabolites in the testicles of rats after regular cocoa consump-
tion. (a) Epicatechin-7-O-glucuronide (tentatively) at peak 1 (MRM 465/289).
(b) Methylepicatechin glucuronides 1 and 2 at peaks 2 and 3, respectively
(MRM 479/303). cps, Counts per s.
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coherent with its late elution as compared with the epicatechin-5-
O-glucuronide standard(18). The HPLC elution behaviour of epi-
catechin-glucuronides found in human subjects and rats
reported by Natsume et al. (22) would also be in accordance
with our previous results in which, after cocoa consumption,
a major glucuronide with higher retention time in human sub-
jects than in rats was found(13). Furthermore, following Nat-
sume’s observations, we tentatively identified the major
methyl-glucuronide derivative (peak 3, Fig. 1) as 30-O-
methyl-(2)-epicatechin-7-O-glucuronide.
The present results are also consistent with previous studies.
Thus, one epicatechin glucuronide and one 30-O-methylepica-
techin glucuronide were found in rat brain tissue after
the administration of 100 mg(2 )-epicatechin/kg per d over
10 d(23). Furthermore, the metabolites detected in rat
tissues in the present study matched the findings of other
authors who detected epicatechin-glucuronide and methylepi-
catechin glucuronide in the plasma, gastrointestinal tract, liver
and kidneys of rats after feeding with grapeseed extract(24).
Predominant metabolites in rat plasma and bile after oral
administration of (2 )-epicatechin were found to be glucuro-
nide conjugates of 30-O-methyl-(2)-epicatechin at concen-
trations about 7-fold higher than other (2 )-epicatechin
conjugates that were secondary metabolites(25).
There are no studies about the accumulation of epicatechin
metabolites in tissues after cocoa intake but the presence of
catechins after tea consumption has been reported in several
tissues. After maternal exposure to green tea extracts, tea
catechins were detected in most of the fetal rat organs
(brain, eyes, heart, lungs, kidneys and liver), catechin gallates
being more readily taken up than catechins(26). Tea catechins
and theaflavins were found in the small and large intestine,
liver and prostate in conjugated and free forms after adminis-
tration of black tea to mice(27). After administration of
10mmol [3H]epicatechin to rats, major amounts of radio-
activity were observed in the large intestine and caecum at
24 h, and little radioactivity was observed in the stomach,
plasma, small intestine, blood and testes(28).
As shown here, epicatechin metabolites were accumulated
in concentrations 2-fold higher in the thymus, testes and
liver than in lymphoid nodes and spleen. The high amounts
of epicatechin metabolites accumulated in the thymus corre-
late well with previous findings demonstrating an increase in
thymus superoxide dismutase and catalase activities after
cocoa consumption in rats(16). Furthermore, the fact that the
activity of these antioxidant enzymes is not affected in the
liver or spleen(16) might be explained by the minor concen-
tration found in the spleen and lower epicatechin glucuronide
levels in the liver.
The accumulation of epicatechin metabolites in the thymus
could affect lymphocyte composition in this tissue, because a
cocoa diet in rats seems to favour T cell development(16).
Moreover, although the tissue accumulation was less, rats
fed cocoa also exhibited modifications in spleen cell
composition and, interestingly, changes in lymphocyte
functionality, increasing proliferation rate and decreasing
IL-4 secretion(6).
In addition, epicatechin metabolites have also been observed
in mesenteric lymph nodes, which belong to gut-associated
lymphoid tissue (GALT) compartments. Ramiro-Puig et al. (7)
demonstrated changes in GALT lymphocyte composition in
young rats, such as decreases in the Th percentage and
increases in gd T cell percentage. These changes observed in
mesenteric lymph nodes and in lymphocyte composition
could result from epicatechin metabolites accumulated in
these tissues.
The relatively high concentration of epicatechin metabolites
found in the testes, mainly epicatechin glucuronide, shows
that an accumulation could occur. To our knowledge, there
are not many studies about the accumulation of epicatechin
metabolites and their effect on the testes. Previously, a diet
containing 0·5 to 2 % cocoa-rich flavanols given to male rats
over a period of 2 weeks showed a dose-dependent reduction
in oxidative DNA damage in rat testes, as concluded from
the decrease of levels in a marker of DNA oxidation,
8-hydroxy-20-deoxyguanosine(29). This reduction in oxidative
damage in the testes after cocoa intake could be due to the
accumulation of epicatechin metabolites in the testes. To our
knowledge, only low activities for epicatechin metabolites
have been described until now. With regards to structure–
activity, it has been shown that substitution of the hydroxyls
in the catechol B-ring of catechins results in a decrease of
the antioxidant activity(19). Flavonoids containing an unsub-
stituted catechol B-ring do not inhibit NADPH oxidase, but
scavenge the superoxide radical(30,31), suggesting that the
o-dihydroxy catechol structure in the B-ring is the most
important factor for protecting against oxidation(31). The
O-methylation of catechol arrangement in the B-ring converts
the flavonoid to an NADPH oxidase inhibitor(30), affording
a plausible explanation for the improvement of endothelial
function and bioavailability of NO in human subjects after
the intake of epicatechin products(32).
In conclusion, in the present study we show that epicatechin
is absorbed from the complex matrix that is cocoa, it is
metabolised in glucuronide and methylated forms and distrib-
uted in the testicles, liver and lymphoid organs (thymus,
spleen and lymphoid nodes). Further studies should be done
to evaluate the bioactivity of these metabolites, which could
contribute to explain whether that accumulation is related to
the biological activity associated with flavanol consumption.
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